Huntington's disease: degradation of mutant huntingtin by autophagy

Sovan Sarkar, David C Rubinsztein

Research output: Contribution to journalArticlepeer-review

149 Citations (Scopus)

Abstract

Autophagy is a nonspecific bulk degradation pathway for long-lived cytoplasmic proteins, protein complexes, or damaged organelles. This process is also a major degradation pathway for many aggregate-prone, disease-causing proteins associated with neurodegenerative disorders, such as mutant huntingtin in Huntington's disease. In this review, we discuss factors regulating the degradation of mutant huntingtin by autophagy. We also report the growing list of new drugs/pathways that upregulate autophagy to enhance the clearance of this mutant protein, as autophagy upregulation may be a tractable strategy for the treatment of Huntington's disease.

Original languageEnglish
Pages (from-to)4263-70
Number of pages8
JournalThe FEBS journal
Volume275
Issue number17
DOIs
Publication statusPublished - Sept 2008

Keywords

  • Autophagy
  • Humans
  • Huntington Disease
  • Inositol
  • Lithium Compounds
  • Mutation
  • Nerve Tissue Proteins
  • Nuclear Proteins
  • Protein Kinases
  • Sirolimus
  • TOR Serine-Threonine Kinases
  • Trehalose

Fingerprint

Dive into the research topics of 'Huntington's disease: degradation of mutant huntingtin by autophagy'. Together they form a unique fingerprint.

Cite this